Interesting question; incidentally no straight answer . Management change is always Binary “0” or “1”.
How in case of HCG this becomes more interesting:
Pro’s for new management:
- Tailwinds in the sector.
- M&A opportunities (outgoing management has initiated the process)
Cons for new management:
- Frequent change in ownership might be demotivating for the staff.
- Technology upgradations might require deep pockets & swift actions.
- Competition from Multi Speciality of hospitals : Most of established players are either opening or expanding Oncology department at their sites.
So no straight answer, trust this gives some insight.
Disc : Existed recently, considering risk / reward in HCG v/s Peers
| Subscribe To Our Free Newsletter |
